Dexmedetomidine inhibits the secretion of high mobility group box 1 from lipopolysaccharide-activated macrophages in vitro

Journal of Surgical Research

Volumn 181, Issue 2, 2013, Pages 308-314

  Chang, Yulin ^a   Huang, Xiaojing ^b   Liu, Zhaohui ^a   Han, Guangwei ^c   Huang, Lina ^c   Xiong, Yuan Chang ^b   Wang, Zhengping ^d  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d TONGJI UNIVERSITY   (China)

Author keywords

2 Adrenergic receptors; Dexmedetomidine; High mobility group box 1; Lipopolysaccharides; NF B

Indexed keywords

DEXMEDETOMIDINE; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; TRANSCRIPTION FACTOR RELA; YOHIMBINE;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CELL LINE; DEXMEDETOMIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; HMGB1 PROTEIN; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84876419178     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.07.017     Document Type: Article

References (37)

1. B. Beutler, I.W. Milsark, and A.C. Cerami Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin Science 229 1985 869
2. K.J. Tracey, B. Beutler, and S.F. Lowry Shock and tissue injury induced by recombinant human cachectin Science 234 1986 470
3. M.P. Glauser, G. Zanetti, and J.D. Baumgartner Septic shock: pathogenesis Lancet 338 1991 732
4. H. Wang, O. Bloom, and M. Zhang HMG-1 as a late mediator of endotoxin lethality in mice Science 285 1999 248
5. J. Bernhagen, T. Calandra, and R. Mitchell MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia Nature 365 1993 756
6. K. Ohlsson, P. Bjork, and M. Bergenfeldt Interleukin-1 receptor antagonist reduces mortality from endotoxin shock Nature 348 1990 550
7. U. Andersson, H. Wang, and K. Palmblad High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes J Exp Med 192 2000 565
8. D. Stern, S.D. Yan, and S.F. Yan Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings Adv Drug Deliv Rev 54 2002 1615
9. J.S. Park, D. Svetkauskaite, and Q. He Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein J Biol Chem 279 2004 7370
10. D. Tang, R. Kang, and W. Xiao Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function Am J Respir Cell Mol Biol 41 2009 651
11. K. Tsoyi, H.J. Jang, and I.T. Nizamutdinova Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice Br J Pharmacol 162 2011 1498
12. S. Barnay-Verdier, L. Fattoum, and C. Borde Emergence of autoantibodies to HMGB1 is associated with survival in patients with septic shock Intens Care Med 37 2011 957
13. H. Yang, H. Wang, and C.J. Czura The cytokine activity of HMGB1 J Leukoc Biol 78 2005 1
14. D.S. Carollo, B.D. Nossaman, and U. Ramadhyani Dexmedetomidine: a review of clinical applications Curr Opin Anaesthesiol 21 2008 457
15. A. Arcangeli, C. D'Alo, and R. Gaspari Dexmedetomidine use in general anaesthesia Curr drug targets 10 2009 687
16. T. Taniguchi, Y. Kidani, and H. Kanakura Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats Crit Care Med 32 2004 1322
17. C.L. Yang, C.H. Chen, and P.S. Tsai Protective effects of dexmedetomidine-ketamine combination against ventilator-induced lung injury in endotoxemia rats J Surg Res 167 2011 e273
18. H. Okada, T. Kurita, and T. Mochizuki The cardioprotective effect of dexmedetomidine on global ischaemia in isolated rat hearts Resuscitation 74 2007 538
19. H. Kocoglu, H. Ozturk, and F. Yilmaz Effect of dexmedetomidine on ischemia-reperfusion injury in rat kidney: a histopathologic study Ren Fail 31 2009 70
20. K. Engelhard, C. Werner, and E. Eberspächer The effect of the α2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S (+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats Anesth Analg 96 2003 524
21. V. Hanci, B. Erol, and S. Bektas Effect of dexmedetomidine on testicular torsion/detorsion damage in rats Urol Int 84 2010 105
22. X.Y. Zhang, Z.M. Liu, and S.H. Wen Dexmedetomidine administration before, but not after, ischemia attenuates intestinal injury induced by intestinal ischemia-reperfusion in rats Anesthesiology 116 2012 1035
23. C.Y. Lin, P.S. Tsai, and Y.C. Hung L-type calcium channels are involved in mediating the anti-inflammatory effects of magnesium sulphate Br J Anaesth 104 2010 44
24. T.J. Ebert, J.E. Hall, and J.A. Barney The effects of increasing plasma concentrations of dexmedetomidine in humans Anesthesiology 93 2000 382
25. J.R. Zhou, Z. Xu, and C.L. Jiang Neuropeptide Y promotes TGF-beta1 production in RAW264.7 cells by activating PI3K pathway via Y1 receptor Neurosci Bull 24 2008 155
26. T.D. Schmittgen, and K.J. Livak Analyzing real-time PCR data by the comparative CT method Nature Protocols 3 2008 1101
27. M.A. van Zoelen, H. Yang, and S. Florquin Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo Shock 31 2009 280
28. Y.C. Lai, P.S. Tsai, and C.J. Huang Effects of dexmedetomidine on regulating endotoxin-induced up-regulation of inflammatory molecules in murine macrophages J Surg Res 154 2009 212
29. P.P. Pandharipande, B.T. Pun, and D.L. Herr Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial JAMA 298 2007 2644
30. K.P. Mason, D. Zurakowski, and S.E. Zgleszewski High dose dexmedetomidine as the sole sedative for pediatric MRI Pediatr Anesth 18 2008 403
31. J.Y. Kim, J.S. Park, and D. Strassheim HMGB1 contributes to the development of acute lung injury after hemorrhage Am J Physiol Lung Cell Mol Physiol 288 2005 L958
32. M. Shibasaki, M. Sasaki, and M. Miura Induction of high mobility group box-1 in dorsal root ganglion contributes to pain hypersensitivity after peripheral nerve injury Pain 149 2010 514
33. M. Andrassy, H.C. Volz, and J.C. Igwe High-mobility group box-1 in ischemia-reperfusion injury of the heart Circulation 117 2008 3216
34. S. Zhang, J. Zhong, and P. Yang HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes Int J Clin Exp Pathol 3 2010 24
35. Z. Liu, J. Zhang, and X. Huang Magnesium sulfate inhibits the secretion of high mobility group box 1 from lipopolysaccharide-activated RAW264.7 macrophages in vitro J Surg Res 2012 Mar 28 [Epub]
36. Z. Liu, Y. Chang, and J. Zhang Magnesium deficiency promotes secretion of high-mobility group box 1 protein from lipopolysaccharide-activated macrophages in vitro J Surg Res 2012 May 10 [Epub]
37. D.B. Bylund Subtypes of alpha 1- and alpha 2-adrenergic receptors FASEB J 6 1992 832